- Salli U. Fox TE. Carkaci-Salli N. Sharma A. Robertson GP. Kester M. Vrana K. Propagation of undifferentiated human embryonic stem cells with nano-liposomal ceramide. 2008 Mar 10. Stem Cells Dev. .
|
- Tran MA. Smith CD. Kester M. Robertson GP. Combining nanoliposomal ceramide with sorafenib synergistically inhibits melanoma and breast cancer cell survival to decrease tumor development. 2008 Jun 1. Clin Cancer Res. 14(11):3571-81.
|
- Sun Y. Fox T. Adhikary G. Kester M. Pearlman E. Inhibition of corneal inflammation by liposomal delivery of short-chain, C-6 ceramide. 2008 Jun. J Leukoc Biol. 83(6):1512-21.
|
- Stover TC. Kim YS. Lowe TL. Kester M. Thermoresponsive and biodegradable linear-dendritic nanoparticles for targeted and sustained release of a pro-apoptotic drug. 2008 Jan. Biomaterials. 29(3):359-69.
|
- Fox TE. Houck KL. O'Neill SM. Nagarajan M. Stover TC. Pomianowski PT. Unal O. Yun JK. Naides SJ. Kester M. Ceramide recruits and activates protein kinase C zeta (PKC zeta) within structured membrane microdomains. 2007 Apr 27. J Biol Chem. 282(17):12450-7.
National Heart, Lung, and Blood Institute |
- Antonetti DA. Barber AJ. Bronson SK. Freeman WM. Gardner TW. Jefferson LS. Kester M. Kimball SR. Krady JK. LaNoue KF. Norbury CC. Quinn PG. Sandirasegarane L. Simpson IA. JDRF Diabetic Retinopathy Center Group. Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. 2006 Sep. Diabetes. 55(9):2401-11.
National Eye Institute |
- Fox TE. Finnegan CM. Blumenthal R. Kester M. The clinical potential of sphingolipid-based therapeutics. 2006 May. Cell Mol Life Sci. 63(9):1017-23.
|
- Basile M. Lin R. Kabbani N. Karpa K. Kilimann M. Simpson I. Kester M. Paralemmin interacts with D3 dopamine receptors: implications for membrane localization and cAMP signaling. 2006 Feb 1. Arch Biochem Biophys. 446(1):60-8.
|
- Fox TE. Han X. Kelly S. Merrill AH. Martin RE. Anderson RE. Gardner TW. Kester M. Diabetes alters sphingolipid metabolism in the retina: a potential mechanism of cell death in diabetic retinopathy. 2006 Dec. Diabetes. 55(12):3573-80.
National Institute on Aging
National Eye Institute
National Center for Research Resources |
- Stover TC. Sharma A. Robertson GP. Kester M. Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma. 2005 May 1. Clin Cancer Res. 11(9):3465-74.
National Heart, Lung, and Blood Institute |
- Stahl JM. Sharma A. Cheung M. Zimmerman M. Cheng JQ. Bosenberg MW. Kester M. Sandirasegarane L. Robertson GP. Deregulated Akt3 activity promotes development of malignant melanoma. 2004 Oct 1. Cancer Res. 64(19):7002-10.
|
- Reiter CE. Sandirasegarane L. Wolpert EB. Klinger M. Simpson IA. Barber AJ. Antonetti DA. Kester M. Gardner TW. Characterization of insulin signaling in rat retina in vivo and ex vivo. 2003 Oct. Am J Physiol Endocrinol Metab. 285(4):E763-74.
National Institute of General Medical Sciences |
- Stover T. Kester M. Liposomal delivery enhances short-chain ceramide-induced apoptosis of breast cancer cells. 2003 Nov. J Pharmacol Exp Ther. 307(2):468-75.
National Heart, Lung, and Blood Institute |
- Kester M. Kolesnick R. Sphingolipids as therapeutics. 2003 May. Pharmacol Res. 47(5):365-71.
National Cancer Institute
National Institute of Diabetes and Digestive and Kidney Diseases
National Heart, Lung, and Blood Institute |
- Bourbon NA. Sandirasegarane L. Kester M. Ceramide-induced inhibition of Akt is mediated through protein kinase Czeta: implications for growth arrest. 2002 Feb 1. J Biol Chem. 277(5):3286-92.
National Institute of Diabetes and Digestive and Kidney Diseases
National Heart, Lung, and Blood Institute |
- Yun JK. Kester M. Regulatory role of sphingomyelin metabolites in hypoxia-induced vascular smooth muscle cell proliferation. 2002 Dec 1. Arch Biochem Biophys. 408(1):78-86.
National Cancer Institute
National Institute of Diabetes and Digestive and Kidney Diseases
National Heart, Lung, and Blood Institute |
- Bourbon NA. Yun J. Berkey D. Wang Y. Kester M. Inhibitory actions of ceramide upon PKC-epsilon/ERK interactions. 2001 Jun. Am J Physiol Cell Physiol. 280(6):C1403-11.
National Institute of Diabetes and Digestive and Kidney Diseases |
- Sandirasegarane L. Kester M. Enhanced stimulation of Akt-3/protein kinase B-gamma in human aortic smooth muscle cells. 2001 Apr 27. Biochem Biophys Res Commun. 283(1):158-63.
National Institute of Diabetes and Digestive and Kidney Diseases |
- Kester M. Waybill P. Kozak M. New strategies to prevent restenosis. 2001. Am J Cardiovasc Drugs. 1(2):77-83.
National Institute of Diabetes and Digestive and Kidney Diseases |
- Bourbon NA. Yun J. Kester M. Ceramide directly activates protein kinase C zeta to regulate a stress-activated protein kinase signaling complex. 2000 Nov 10. J Biol Chem. 275(45):35617-23.
National Institute of Diabetes and Digestive and Kidney Diseases |
- Sandirasegarane L. Charles R. Bourbon N. Kester M. NO regulates PDGF-induced activation of PKB but not ERK in A7r5 cells: implications for vascular growth arrest. 2000 Jul. Am J Physiol Cell Physiol. 279(1):C225-35.
National Institute of Diabetes and Digestive and Kidney Diseases |
- Charles R. Sandirasegarane L. Yun J. Bourbon N. Wilson R. Rothstein RP. Levison SW. Kester M. Ceramide-coated balloon catheters limit neointimal hyperplasia after stretch injury in carotid arteries. 2000 Aug 18. Circ Res. 87(4):282-8.
National Institute of Diabetes and Digestive and Kidney Diseases |
